All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @ashley.raibick on TikTok · 101s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @ashley.raibick's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It's injection time. If you follow along, I know what you're thinking. I was supposed to take 20 units weekly starting last week.
  2. 0:05I was originally taking 40 units every two weeks.
  3. 0:08I decided that I was gonna cut it in half and do weekly for maintenance just because I didn't feel great from the one injection of 40 units,
  4. 0:14even though I've been doing it for so long.
  5. 0:15I just feel like it's spaced out too much and too high.
  6. 0:18So I'm actually going to 20 every week, but I am going on a flight tomorrow to Disney.
  7. 0:23So excited. And I figured out that if I took the injection when I was supposed to,
  8. 0:27I was going to end up overlapping and needing to bring an injection with me to Disney.
  9. 0:31And I didn't want to do that.
  10. 0:32I am going to inject myself right now with 20 units.
  11. 0:35And again, on Friday when I come home and we are going to start weekly and see how we do.
  12. 0:39If I start to lose weight, then I am going to have to change my dose and go lower.
  13. 0:44I have a feeling that that may happen just because putting it in my body weekly at 20 units.
  14. 0:49I was losing weight originally. So we'll see.
  15. 0:51I'll definitely keep you guys updated and let you know.
  16. 0:53But for right now, 20 units, here we go.
  17. 0:56I'm serious.
  18. 0:57Poke it. Flip it.
  19. 0:59Still makes me nervous. I get so much anxiety doing this.
  20. 1:02I could have never been a nurse.
  21. 1:03Nurses. I give you guys so much freaking credit.
  22. 1:06Just like nervous. Do we think 20 is going to work?
  23. 1:09Like in my own head now.
  24. 1:10I do self-camera because I have nothing under my room.
  25. 1:13That was the first time that ever happened to me.
  26. 1:14I literally went to poke myself.
  27. 1:16I got nervous and I hesitated.
  28. 1:18And then I poked and I took it out and then I repoked it.
  29. 1:23I don't even know if you can do that.
  30. 1:25Oh, we're injected 20 units better work because if not, I'm going to be eating through Disney.
  31. 1:32So say your prayer for me.
  32. 1:34I think you will. I think we're going to be right.
  33. 1:36I will check back in on Friday. Wish me luck in Disney.

@ashley.raibick's semaglutide content, fact-checked

A S H L E Y R A I B I C K

TikTok creator

35.1K viewsWatch on TikTok

Quick answer

Ashley appears to be using a compounded semaglutide preparation dosed in units, and has self-directed a switch from 40 units biweekly to 20 units weekly based on subjective side effect management. She further compressed her dosing interval to avoid carrying medication during travel, which creates a shorter-than-weekly window not consistent with standard semaglutide protocols. No prescriber involvement is mentioned in this dose adjustment decision, which raises real concerns given the variable potency of compounded preparations.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @ashley.raibick's semaglutide content, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@ashley.raibick's semaglutide content, fact-checked" from A S H L E Y R A I B I C K. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Ashley appears to be using a compounded semaglutide preparation dosed in units, and has self-directed a switch from 40 units biweekly to 20 units weekly based on subjective side effect management.

The reason this review is not generic is the source wording and the canonical claim label "glp1 semaglutide girl things glp1forweightloss semaglutideforwe." In this clip, the useful excerpt is: "It's injection time." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The STEP 1 trial (Wilding et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Ashley appears to be using a compounded semaglutide preparation dosed in units, and has self-directed a switch from 40 units biweekly to 20 units weekly based on subjective side effect management.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Ashley appears to be using a compounded semaglutide preparation dosed in units, and has self-directed a switch from 40 units biweekly to 20 units weekly based on subjective side effect management. She further compressed her dosing interval to avoid carrying medication during travel, which creates a shorter-than-weekly window not consistent with standard semaglutide protocols. No prescriber involvement is mentioned in this dose adjustment decision, which raises real concerns given the variable potency of compounded preparations.
  • Semaglutide has a half-life of approximately 165 to 184 hours, which is why once-weekly dosing produces stable blood levels. Compressing or skipping days undermines that stability.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) found that all dose adjustments in semaglutide protocols were provider-supervised, not patient-initiated based on personal comfort.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Semaglutide has a half-life of approximately 165 to 184 hours, which is why once-weekly dosing produces stable blood levels. Compressing or skipping days undermines that stability.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) found that all dose adjustments in semaglutide protocols were provider-supervised, not patient-initiated based on personal comfort.
  • The FDA issued a 2023 safety alert noting that compounded semaglutide products vary in potency and labeling, making DIY unit-based dose splitting riskier than it appears.
  • Injecting earlier than scheduled to avoid bringing medication on a trip shortens the dosing interval, which is not the same as switching to weekly dosing and has no clinical basis.
  • Self-reducing doses in response to weight loss is not a validated strategy. Dose changes should reflect a prescriber's assessment of tolerability, efficacy, and health status.
  • Feeling unwell on a GLP-1 dose is a legitimate clinical signal, but the appropriate response is contacting your prescriber, not independently restructuring your injection schedule on camera.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @ashley.raibick actually say?

Ashley described switching from 40 units every two weeks to 20 units weekly, saying she "didn't feel great" on the biweekly schedule and felt the doses were "spaced out too much and too high." She also admitted to injecting early before a Disney trip to avoid carrying medication, then planning to inject again on Friday upon return, effectively compressing her dosing window.

She also floated the idea that if she starts losing weight again, she'll need to drop her dose lower. No prescriber was mentioned as part of this decision. The entire adjustment appears to be self-directed.

To be clear about what "units" means here: semaglutide pens prescribed for weight management are typically dosed in milligrams, but some compounded semaglutide preparations are drawn in units from a vial. This matters, because the concentration of compounded preparations varies by pharmacy, making unit-based dosing especially sensitive to errors.

Does the science back this up?

The pharmacology of weekly dosing has merit on paper, but the self-adjustment part is where things get complicated. Semaglutide has a half-life of approximately seven days, which is precisely why it was designed as a once-weekly injection. Splitting a two-week dose into two weekly doses is not inherently irrational from a pharmacokinetic standpoint.

The approved dosing protocols for semaglutide (Wilding et al., 2021, NEJM) use fixed weekly intervals with gradual titration supervised by a clinician. The STEP 1 trial found that dose escalation decisions were tied to tolerability under medical oversight, not self-reported symptom management. When patients in trials experienced nausea or other side effects, dose adjustments were made by providers, not independently.

The concern with self-adjusting compounded semaglutide is compounded, no pun intended, by the fact that concentration standardization across compounding pharmacies is inconsistent. A 2023 FDA alert noted that compounded semaglutide products vary in potency and labeling, making DIY dose splitting harder to execute accurately than it sounds.

What did they get wrong (or right)?

She got one thing partially right: weekly dosing is how FDA-approved semaglutide is actually prescribed. If her original biweekly schedule was truly 40 units every two weeks, switching to 20 units weekly could theoretically deliver a more stable plasma concentration, which aligns with how the drug is meant to work.

But here is what she got wrong. Adjusting the timing of her injection specifically to avoid carrying medication on a trip is not a clinical reason to shift a dosing schedule. She explicitly said she injected early and planned to inject again in a compressed window on Friday. That shortens her interval below seven days, which is not the same as weekly dosing. It is self-titrating around vacation logistics, and no study supports that as a safe or effective approach.

She also casually suggested that future weight loss would require her to lower her dose further, treating dose reduction as a self-managed response to efficacy. That is a decision that should involve a prescriber, not a TikTok check-in.

What should you actually know?

Semaglutide's once-weekly schedule is not arbitrary. Its half-life of roughly 165 to 184 hours (Kapitza et al., 2015, Diabetes, Obesity and Metabolism) means that consistent weekly dosing produces relatively stable blood levels. Compressing or shifting injection timing disrupts that stability, which can affect both side effect profiles and efficacy.

Self-adjusting GLP-1 doses without provider input is a real pattern in the current landscape of compounded semaglutide use, and it carries real risks. Overdosing can cause severe nausea, vomiting, and hypoglycemia in certain populations. Underdosing can result in loss of appetite suppression and weight regain.

If you are on a compounded semaglutide protocol and feeling unwell at your current dose, that is a conversation to have with your prescriber, not a problem to solve with a calculator and a calendar. The clinical reasons behind titration schedules exist because individual response varies significantly, and those adjustments should be guided by someone who knows your full health history.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

A S H L E Y R A I B I C K · TikTok creator

35.1K views on this video

Semaglutide girl things #glp1forweightloss #semaglutideforweightloss #weightlossmedication #weightlosstransformation

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about semaglutide has a half-life of approximately 165 to 184 hours,?

Semaglutide has a half-life of approximately 165 to 184 hours, which is why once-weekly dosing produces stable blood levels. Compressing or skipping days undermines that stability.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) found?

The STEP 1 trial (Wilding et al., 2021, NEJM) found that all dose adjustments in semaglutide protocols were provider-supervised, not patient-initiated based on personal comfort.

What does the video say about the fda?

The FDA issued a 2023 safety alert noting that compounded semaglutide products vary in potency and labeling, making DIY unit-based dose splitting riskier than it appears.

What does the video say about injecting earlier than scheduled to avoid bringing medication on a?

Injecting earlier than scheduled to avoid bringing medication on a trip shortens the dosing interval, which is not the same as switching to weekly dosing and has no clinical basis.

What does the video say about self-reducing doses in response to weight loss?

Self-reducing doses in response to weight loss is not a validated strategy. Dose changes should reflect a prescriber's assessment of tolerability, efficacy, and health status.

What does the video say about feeling unwell on a glp-1 dose?

Feeling unwell on a GLP-1 dose is a legitimate clinical signal, but the appropriate response is contacting your prescriber, not independently restructuring your injection schedule on camera.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by A S H L E Y R A I B I C K, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.